Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Noom Med vs WeightRx

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.6

Noom Med

Best for psychology + medication combo
★★★★4.3

Starting at $99/mo

GLP-1 IntegrationCBT CoachingDietitian
Visit Noom Med
7.7

WeightRx

Best for budget-conscious shoppers
★★★3.9

Starting at $99/mo

CompoundedSemaglutide
Visit WeightRx

Side-by-Side Comparison

FeatureNoom MedWeightRx
Overall Score8.6/107.7/10
Starting Price$99/mo$99/mo
Editorial Rating4.3 ★ /53.9 ★ /5
Features3 features2 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Noom Med

Pros

  • Combines GLP-1 medication with CBT behavior change
  • Dedicated dietitian included in every plan
  • Highest support score in fitness app category
  • Integrated care team for medication and coaching
  • Noom's proven behavioral curriculum

Cons

  • Available in only 40 states — excludes AK, HI, ID, MT, NM, SD, VT, WV, WY, ND
  • More expensive than app-only alternatives
  • Requires commitment to both medication and coaching program

WeightRx

Pros

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Cons

  • Limited public information on program details

Our Verdict

Winner: Noom MedScore: 8.6/10

Noom Med edges out WeightRx with a higher overall score of 8.6/10 and is particularly strong for psychology + medication combo. WeightRx remains a solid alternative, especially if you're looking for budget-conscious shoppers.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.